Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.23%2.04B | -9.64%2.66B | -16.28%10.03B | -19.59%2.55B | -18.84%2.5B | -12.59%2.03B | -13.37%2.94B | -1.35%11.98B | -7.48%3.17B | -5.08%3.09B |
Cost of revenue | -4.25%776.67M | -8.87%1B | -19.42%3.87B | -25.01%1.03B | -17.61%926.51M | -15.25%811.14M | -18.18%1.1B | -5.51%4.8B | -11.46%1.38B | -13.02%1.12B |
Gross profit | 3.20%1.26B | -10.11%1.65B | -14.17%6.16B | -15.43%1.52B | -19.55%1.58B | -10.72%1.22B | -10.22%1.84B | 1.64%7.17B | -4.18%1.8B | 0.15%1.96B |
Operating expense | -6.75%1.36B | -14.59%1.45B | -22.13%6.2B | -17.07%1.57B | -23.64%1.47B | -25.05%1.46B | -22.57%1.7B | -13.60%7.96B | -22.50%1.89B | -14.99%1.93B |
Staff costs | ---- | ---- | -25.95%2.02B | ---- | ---- | ---- | ---- | -15.92%2.72B | ---- | ---- |
Selling and administrative expenses | ---- | ---- | -18.90%1.28B | ---- | ---- | ---- | ---- | -16.51%1.58B | ---- | ---- |
-Selling and marketing expense | ---- | ---- | -12.75%495.09M | ---- | ---- | ---- | ---- | -19.67%567.44M | ---- | ---- |
-General and administrative expense | ---- | ---- | -22.35%785.61M | ---- | ---- | ---- | ---- | -14.62%1.01B | ---- | ---- |
Depreciation and amortization | ---- | ---- | -28.23%173.17M | ---- | ---- | ---- | ---- | -9.29%241.28M | ---- | ---- |
-Depreciation | ---- | ---- | -28.23%173.17M | ---- | ---- | ---- | ---- | -9.29%241.28M | ---- | ---- |
Rent and land expenses | ---- | ---- | -21.85%1.55B | ---- | ---- | ---- | ---- | -15.61%1.99B | ---- | ---- |
Other operating expenses | ---- | ---- | -17.75%1.17B | ---- | ---- | ---- | ---- | -2.18%1.42B | ---- | ---- |
Operating profit | 57.81%-100.36M | 44.33%201.88M | 94.83%-40.6M | 48.56%-48.16M | 219.16%105.57M | 58.89%-237.89M | 195.86%139.87M | 63.54%-785.16M | 83.41%-93.62M | 110.67%33.08M |
Net non-operating interest income (expenses) | 42.82%-11.63M | 3.77%-19.76M | 2.80%-80.92M | 1.19%-19.98M | 2.57%-20.06M | 3.17%-20.35M | 4.18%-20.54M | -35.39%-83.25M | 6.25%-20.22M | -16.13%-20.59M |
Non-operating interest income | ---- | ---- | -50.00%1K | ---- | ---- | ---- | ---- | --2K | ---- | ---- |
Non-operating interest expense | -42.82%11.63M | -3.77%19.76M | -2.80%80.92M | -1.20%19.98M | -2.57%20.06M | -3.17%20.35M | -4.18%20.54M | 35.39%83.25M | -6.24%20.22M | 16.13%20.59M |
Net investment income | 0.00%6.4M | 0.00%6.4M | ||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -19.9M | ||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | 84,941.57%1.5B | 64.72%-90.61M | 64.91%-88.85M | 0 | 0 | 15.73%-1.77M | -635.21%-256.82M | -1,028.54%-253.19M | 0 |
Less:Restructuring and mergern&acquisition | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --164.09M | ---- | ---- |
Less:Other special charges | --0 | ---1.5B | 217.70%3.43M | ---- | ---- | ---- | ---- | -54.68%1.08M | ---- | ---- |
Less:Write off | --0 | --0 | -4.87%87.19M | -2.96%85.42M | --0 | --0 | -15.73%1.77M | 181.56%91.65M | 338.91%88.02M | --0 |
Other non-operating income (expenses) | 12.43%50.56M | 21.37%46.26M | 9.30%170.96M | 59.58%34.16M | 30.10%53.72M | -1.08%44.97M | -21.01%38.12M | -46.30%156.41M | -49.47%21.41M | -40.94%41.29M |
Income before tax | 71.19%-61.44M | 1,010.19%1.73B | 96.46%-34.78M | 67.58%-116.42M | 158.91%139.22M | 61.63%-213.26M | 228.45%155.68M | 49.69%-982.32M | 35.82%-359.12M | 120.86%53.77M |
Income tax | -2.71%17.08M | -4.14%17.85M | -0.98%67.39M | -9.01%13.87M | 7.01%17.35M | -1.85%17.56M | -0.54%18.62M | -64.88%68.06M | -4.23%15.24M | -10.95%16.21M |
Net income | 65.98%-78.52M | 1,148.00%1.71B | 90.27%-102.17M | 65.20%-130.29M | 224.47%121.88M | 59.76%-230.82M | 197.96%137.06M | 51.06%-1.05B | 34.94%-374.36M | 113.61%37.56M |
Net income continuous operations | 65.98%-78.52M | 1,147.99%1.71B | 90.27%-102.17M | 65.20%-130.29M | 224.47%121.87M | 59.76%-230.82M | 197.96%137.06M | 51.06%-1.05B | 34.94%-374.36M | 113.61%37.56M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 65.98%-78.52M | 1,148.00%1.71B | 90.27%-102.17M | 65.20%-130.29M | 224.47%121.88M | 59.76%-230.82M | 197.96%137.06M | 51.06%-1.05B | 34.94%-374.36M | 113.61%37.56M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 65.98%-78.52M | 1,148.00%1.71B | 90.27%-102.17M | 65.20%-130.29M | 224.47%121.88M | 59.76%-230.82M | 197.96%137.06M | 51.06%-1.05B | 34.94%-374.36M | 113.61%37.56M |
Gross dividend payment | ||||||||||
Basic earnings per share | 63.50%-3.46 | 1,146.54%70.18 | 90.28%-4.19 | 65.23%-5.34 | 224.68%5 | 59.75%-9.48 | 198.08%5.63 | 51.06%-43.11 | 34.97%-15.36 | 113.59%1.54 |
Diluted earnings per share | 63.50%-3.46 | 882.06%55.29 | 90.28%-4.19 | 65.20%-5.3474 | 224.68%5 | 59.75%-9.48 | 198.08%5.63 | 51.06%-43.11 | 34.95%-15.3646 | 113.59%1.54 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |